|Organ||Ureters - bladder - urethra|
|Trial status||Trial closed for recruitment|
Interventional with experimental drug
|Phase||Trial phase 2|
|Sponsor||Institut Jules Bordet|
|Inclusion criteria||Non metastatic urothelial carcinoma candidate for surgeryCisplatin eligible and ineligible|
The New Jules Bordet Institute, located on the university campus of the ULB in Anderlecht, is ready and will soon welcome its first patients. A new state-of-the-art hospital entirely dedicated to the fight against cancer.